Group 1 - The company has appointed Ernst & Young Hong Kong as the auditing firm for its H-share issuance and listing on the Hong Kong Stock Exchange [1][2][3] - The decision to hire Ernst & Young Hong Kong was made after considering their extensive experience in H-share issuance and their independence and professional capabilities [1][2] - The appointment of the auditing firm requires approval from the company's shareholders' meeting [3] Group 2 - Ernst & Young Hong Kong is registered as a public interest entity auditor under Hong Kong law and has obtained temporary auditing business licenses in mainland China [2] - The firm has a good integrity record, with no significant issues found in the last three years of quality inspections by the Hong Kong Institute of Certified Public Accountants [2] - The company's audit committee reviewed and approved the appointment of Ernst & Young Hong Kong, confirming their qualifications and independence [2][3]
可孚医疗: 关于聘请H股审计机构的公告